Local Angiotensin II Contributes to Tumor Resistance to Checkpoint Immunotherapy

Journal for ImmunoTherapy of Cancer - United Kingdom
doi 10.1186/s40425-018-0401-3
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Related search

Angiotensin II Contributes to the Pathophysiology of Heart Failure

Open Access Journal of Pharmaceutical Research
2018English

CD200 Checkpoint Reversal:A Novel Approach to Immunotherapy

Clinical Cancer Research
Cancer ResearchOncology
2019English

Cytochrome P450 1B1 Contributes to Angiotensin II-Induced Hypertension and Associated Pathophysiology

Hypertension
Internal Medicine
2010English

Resistance to Cancer Immunotherapy Mediated by Apoptosis of Tumor-Infiltrating Lymphocytes

Nature Communications
AstronomyGeneticsMolecular BiologyBiochemistryChemistryPhysics
2017English

Protease-Activated Receptor 1 Contributes to Angiotensin II-Induced Cardiovascular Remodeling and Inflammation

Cardiology
Cardiovascular MedicinePharmacologyCardiology
2016English

Role of Hypokalemia in Vascular Resistance to Angiotensin Ii (Aii)

Pediatric Research
Child HealthPediatricsPerinatology
1977English

Tumor Plasticity Driven by Spatial Micro-Heterogeneity in the Tumor Microenvironment Contributes to Therapy Resistance

Journal of Carcinogenesis & Mutagenesis
2014English

TMEM16A Contributes to Angiotensin II-induced Cerebral Vasoconstriction via the RhoA/ROCK Signaling Pathway

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2016English

MA19.08 Detection of Primary Immunotherapy Resistance to PD-1 Checkpoint Inhibitors (PD1CI) in 2nd Line NSCLC

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy